Table 4. Prevalence of Cardiac Outcomes by Age at Detection.
| Cardiac outcome | Number evaluated | Age at detection (years) | Number evaluable | N | (%) |
|---|---|---|---|---|---|
| Cardiomyopathy | 1586ł | 18-29 | (n=706) | 33 | (4.7) |
| 30-39 | (n=610) | 56 | (9.2) | ||
| ≥ 40 | (n=270) | 29 | (10.7) | ||
| Coronary artery disease | 1853 | 18-29 | (n=791) | 7 | (0.9) |
| 30-39 | (n=701) | 24 | (3.4) | ||
| ≥ 40 | (n=361) | 38 | (10.5) | ||
| Valvular disease | 1742ł | 18-29 | (n=761) | 214 | (28.1) |
| 30-39 | (n=660) | 156 | (23.6) | ||
| ≥ 40 | (n=321) | 118 | (36.8) | ||
| Conduction/rhythm disorders | 1798ł | 18-29 | (n=770) | 21 | (2.7) |
| 30-39 | (n=677) | 21 | (3.1) | ||
| ≥ 40 | (n=350) | 36 | (10.3) |
ł
Only imaging that was successfully completed by the participants and of sufficient quality for interpretation was included, i.e. 1,586 completed the echocardiograms with images adequate for assessment of left ventricular function, 1,742 images were adequate for complete evaluation of valve function, and 1,798 participants completed the electrocardiogram.